Novartis Vaccine and Diagnostics Carriage Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

2,968

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
N. Meningitidis Carriage
Interventions
BIOLOGICAL

Meningococcal B Recombinant + Outer Membrane Vesicle vaccine (rMenB+OMV NZ)

BIOLOGICAL

MenACWY-CRM conjugate vaccine

BIOLOGICAL

Japanese Encephalitis vaccine

Trial Locations (10)

Unknown

Clinical Research Center, University of Surrey, Surrey

Bristol Children's Vaccine Center, University of Bristol,, Bristol, England

Royal Liverpool and Broad Green University Hospital Trust, Liverpool, England

St Georges Vaccine Institute, St Georges, University of London, London, England

Manchester Welcome Trust Clinical Research Facility, University of Manchester, Manchester, England

The James Cook University Hospital, Middlesbrough, England

Cripps Health Centre, University Park, Nottingham, England

University of Oxford, Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, England

Clinical Research Facility, Royal Hallamshire Hospital, Sheffield, England

Wellcome Trust Clinical Research Facility, University of Southampton, Southampton, England

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY